首都医科大学学报

• 核医学与分子影像辅助临床诊疗 • 上一篇    下一篇

抗LGI1抗体自身免疫性脑炎18F-FDG PET/CT影像学特征

李晓桐1,赵晓斌1,吕瑞娟2,袁磊磊1,陈谦1,王群2,艾林1*   

  1. 1.首都医科大学附属北京天坛医院核医学科,北京  100070;2.首都医科大学附属北京天坛医院神经内科,北京  100070
  • 收稿日期:2023-10-18 出版日期:2024-03-21 发布日期:2024-03-21
  • 通讯作者: 艾林 E-mail:E-mail:ailin@bjtth.org
  • 基金资助:
    国家自然科学基金项目(82371449,81771143),北京市自然科学基金项目(7192054)。

18F-FDG PET/CT imaging features of autoimmune encephalitis with anti-LGI1 antibody

Li Xiaotong1, Zhao Xiaobin1, Lyu Ruijuan2, Yuan Leilei1, Chen Qian1, Wang Qun2, Ai Lin1*   

  1. 1.Department of Nuclear Medicine, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070,China; 2. Department of Neurology, Beijing Tiantan Hospital,  Capital Medical University, Beijing  100070,China
  • Received:2023-10-18 Online:2024-03-21 Published:2024-03-21
  • Supported by:
    This study was supported by  National Natural Science Foundation of China  (82371449, 81771143),   Natural Science Foundation of Beijing(7192054).

摘要: 目的  研究抗富亮氨酸胶质瘤失活1蛋白(leucine-rich glioma-inactivated 1,LGI1)抗体自身免疫性脑炎(autoimmune encephalitis,AE)患者头部18F-脱氧葡萄糖(18F-deoxyglucose,FDG)正电子发射计算机断层显像(positron emission tomography,PET)/电子计算机断层显像(computed tomography,CT)影像学特点,探讨PET/CT在抗LGI1-AE早期诊断中的应用价值。方法  回顾性分析2014年10月至2020年11月在首都医科大学附属北京天坛医院神经内科诊断为LGI1-AE的43例患者[其中急性期24例(56%),慢性期19例(44%)]的资料,分析患者18F-FDG PET/CT的影像及临床特征。结果  18F-FDG PET显像结果显示,40例(93%)LGI1-AE患者出现明显的代谢异常,而只有26例(60%)患者出现异常磁共振(magnetic resonance imaging,MRI)信号(P<0.05)。18F-FDG PET代谢异常在治疗后是可逆的,大多数患者出院后18F-FDG PET的代谢几乎均正常。LGI1-AE患者的高代谢区位于基底节区(basal ganglia,BG)和内侧颞叶(medial temporal lobe,MTL)。在33例(77%)患者中观察到BG区高代谢,72%的患者表现出MTL高代谢。共有22例患者(51%)表现出面臂肌张力障碍性癫痫发作(faciobrachial dystonic seizures,FBDS),其余患者表现出非FBDS症状(49%)。FBDS患者中有7例(7/21)检测到仅BG区高代谢,而非FBDS患者中只有2例患者(2/19)检测到BG区高代谢(33% vs 10%,P<0.05)。结论  18F-FDG PET/CT对抗LGI1-AE患者的早期诊断阳性率高。FBDS患者多表现为仅BG区高代谢,这表明BG区可能参与FBDS发作。

关键词: 抗LGI1抗体, 脑炎, 自身免疫性疾病, 脱氧葡萄糖, 正电子发射断层显像术

Abstract: Objective  To study the imaging features of 18F-deoxyglucose (FDG) positron emission tomography(PET)/computed tomography(CT) in the head of patients with anti-leucine-rich glioma-inactivated 1 (LGI1) antibody autoimmune encephalitis (AE), and to evaluate the value of PET/CT in the early diagnosis of anti-LGI1 antibody AE. Methods  The data of 43 patients with LGI1-AE diagnosed in the Department of Neurology, Beijing Tiantan Hospital,  Capital Medical University from October 2014 to November 2020 were retrospectively analyzed, including 24 patients in acute phase (56%), 19 patients in chronic phase (44%), and AE patients whose anti-LGI1 autoimmune antibodies were positive in cerebrospinal fluid or/and serum. The imaging and clinical features of 18F-FDG PET/CT were analyzed. Results  18F-FDG PET imaging showed that 40 LGI1-AE patients (93%) had obvious metabolic abnormalities, while only 26 patients (60%) had abnormal magnetic resonance imaging (MRI) signals (P < 0.05). The abnormal metabolism of 18F-FDG PET is reversible after treatment, and the metabolism of 18F-FDG PET in most patients is almost normal after discharge. The hypermetabolic regions of patients with LGI1-AE are located in the basal ganglia (BG) and medial temporal lobe (MTL). Hypermetabolism in the BG was observed in 33 patients (77%), and hypermetabolism in the MTL was observed in 72% of the patients. A total of 22 patients (51%) showed facial arm dystonia seizures (FBDS), whereas rest showed non-FBDS symptoms (49%). Hypermetabolism in the BG was detected only in 7 patients with FBDS (7/21), while that  detected in only 2 patients without FBDS (2/19) (33% vs 10%). Conclusion  18F-FDG PET imaging was more sensitive in the early diagnosis of LGI1-AE. Most of the patients with FBDS showed hypermetabolism isolated in the BG, suggesting  the potential involvement of the BG.

Key words: anti-leucine-rich glioma-inactivated 1( LGI1)antibody,  , encephalitis, autoimmune disease, 18F-deoxyglucose(18F-FDG), positron emission tomography(PET)

中图分类号: